NCT06462183
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06462183
Title Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rgenta Therapeutics Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Next Oncology VA Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
Ottawa Hospital Cancer Centre Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field